Enalapril/hydrochlorothiazide

From WikiProjectMed
Jump to navigation Jump to search

Enalapril/hydrochlorothiazide
Combination of
EnalaprilACE inhibitor
HydrochlorothiazideThiazide diuretic
Clinical data
Trade namesVaseretic, others
AHFS/Drugs.comMonograph
MedlinePlusa601047
License data
Pregnancy
category
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

Enalapril/hydrochlorothiazide, sold under the brand name Vaseretic among others, is a fixed-dose combination medication used for the treatment of hypertension (high blood pressure).[2] It contains enalapril, an angiotensin converting enzyme inhibitor, and hydrochlorothiazide a diuretic.[2] It is taken by mouth.[2]

The most frequent side effects include dizziness, headache, fatigue, and cough.[2]

History

Enalapril/hydrochlorothiazide was approved for medical use in the United States in October 1986.[2][3]

References

  1. ^ "Enalapril / hydrochlorothiazide (Vaseretic) Use During Pregnancy". Drugs.com. 29 May 2019. Retrieved 26 April 2020.
  2. ^ a b c d e f "Vaseretic- enalapril maleate and hydrochlorothiazide tablet". DailyMed. Retrieved 7 February 2022.
  3. ^ "Vaseretic: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 26 April 2020.

Further reading

  • Frishman WH, Goldberger J, Sherman D (December 1987). "Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension". J Clin Hypertens. 3 (4): 520–7. PMID 2839628.

External links


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://mdwiki.org/wiki/Enalapril/hydrochlorothiazide"